Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients.

Ibrahim Tawhari, Patrick Hallak,Sofia Bin,Fatmah Yamani, Maria Safar-Boueri, Aazib Irshad,Joseph Leventhal,Mohammed Javeed Ansari,Paolo Cravedi,Lorenzo Gallon

Frontiers in immunology（2022）

引用 3|浏览10

暂无评分

摘要

Our data indicate that, in steroid free regimens, low-dose Tac maintenance is needed to prevent rejection when patients are converted to Bela, at least when the maneuver is done early after transplant.

查看译文

关键词

belatacept,kidney transplant,mycophenolate mofeti,renal transplant,tacrolimus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要